Changing the FDA Approval Process
Talk by Susan Desmond-Hellmann, Chancellor of UCSF
Uploaded by Song Essinova, LLC on March 21, 2011
This video is an excerpt of the speaker's talk for the Entrepreneurial Thought Leaders Lecture Series at Stanford University.
Susan Desmond-Hellmann, chancellor of UCSF, has a big idea to change the drug approval process at the Food and Drug Administration (FDA). The current process is binary, allowing for only a yes or no from the reviewer for drug approval. Desmond-Hellmann suggests that a variable approval process, that can change status as greater evidence comes in over time, will encourage more innovative products and even investment funding, based on product confidence.
Tags: Susan Desmond-Hellmann, UCSF, FDA
RELATED
COMMENTS
There are 0 comments. You must be logged in to comment.
Opinions & Expertise
-
Changing the FDA Approval Process
-
Innovating Health Sciences to Reduce Cost
-
Entering the Health Age
-
China's Healthcare Reform
-
The Big Reboot Is Yet to Come - from Mindboggling Science
-
The Synthetic Biology Debate - The Voice for It
-
The Synthetic Biology Debate - The Voice Against It
-
China - Half Way Up the Value Chain, and Growing Rapidly
-
Tough Time Wisdom
-
The System Is Not Optimal!
